Rheumatic Disease Research Core Center
风湿病研究核心中心
基本信息
- 批准号:6801943
- 负责人:
- 金额:$ 55.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-28 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
OVERALL CENTER DESCRIPTION (provided by applicant):
We propose to establish a Rheumatic Diseases Research Core Center at the
University of Tennessee Health Sciences Center, Memphis. Research in rheumatic
diseases at this institution is characterized by a broad based,
multidisciplinary collaboration involving several Departments. We have
identified 26 scientists from 8 different Departments who share a common
interest in rheumatic disease pathogenesis that will form the research base for
this center. The theme of this proposal, "Extracellular matrix, Autoimmunity,
Cytokines and their Receptors in Rheumatic Diseases", represents their
interests and expertise. Individually, these investigators have been very
successful and it is the goal of this center to coordinate their efforts in
rheumatic disease research. The major objective of this proposal is to
encourage rheumatic disease research by enhancing the interaction, efficiency,
and productivity of the participating investigators; supporting novel research
directions; attracting new investigators to the field; encouraging
investigators in other disciplines to consider research in problems related to
rheumatic diseases; and facilitating research involvement by clinical faculty
and fellows. To support these objectives 3 cores are proposed. An
Administrative Core will provide overall coordination, external review, and
support for enrichment activities. A Molecular Resource Core will prepare
collagen, provide state of the art gene quantitation and discovery, and perform
HLA DQ and DR typing. An Animal Resources Core will provide well characterized
transgenic and knock out mice, and flow cytometric analysis of cells involved
in inflammation. Each of the cores will devote substantial effort to education
and training in the use of modem methods and approaches to rheumatic disease
research. We will establish a Pilot and Feasibility Program to encourage
creative endeavors. Included in this application are 3 projects representing
innovative proposals by new investigators. Recently, UTHSC designated
Connective Tissue Research as a Center of Excellence and committed substantial
support for new recruitment. This commitment will enhance our prospect for
success. Strong institutional support for rheumatology, superior physical
resources, and a favorable intellectual environment combine to make this an
opportune time to establish an RDCC at this institution.
中心总体描述(由申请人提供):
我们建议在该中心建立风湿病研究核心中心
田纳西大学健康科学中心,孟菲斯。风湿病研究
该机构的疾病特点是基础广泛、
涉及多个部门的多学科合作。我们有
确定了来自 8 个不同部门的 26 名科学家,他们有一个共同点
对风湿病发病机制的兴趣,这将成为以下研究的基础
这个中心。该提案的主题是“细胞外基质,自身免疫,
风湿病中的细胞因子及其受体”,代表了它们的
兴趣和专业知识。就个人而言,这些调查人员非常
成功,该中心的目标是协调他们的努力
风湿病研究。该提案的主要目标是
通过增强互动、效率、
以及参与研究人员的生产力;支持新颖的研究
方向;吸引新的研究人员来到该领域;鼓励
其他学科的研究人员考虑相关问题的研究
风湿性疾病;并促进临床教师的研究参与
和同胞们。为了支持这些目标,建议使用 3 个核心。一个
行政核心将提供总体协调、外部审查和
支持丰富活动。分子资源核心将准备
胶原蛋白,提供最先进的基因定量和发现,并执行
HLA DQ 和 DR 分型。动物资源核心将提供特征良好的
转基因和基因敲除小鼠,以及相关细胞的流式细胞术分析
处于炎症状态。每个核心都将在教育方面投入大量精力
以及使用现代方法和方法治疗风湿病的培训
研究。我们将建立一个试点和可行性计划来鼓励
创造性的努力。此申请中包括 3 个项目,分别代表
新研究人员提出的创新建议。最近,UTHSC 指定
结缔组织研究作为卓越中心并致力于
支持新的招聘。这一承诺将增强我们的前景
成功。风湿科强大的机构支持,优越的体质
资源和良好的智力环境相结合,使之成为一个
现在是在该机构建立 RDCC 的最佳时机。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW H KANG其他文献
ANDREW H KANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW H KANG', 18)}}的其他基金
Suppression of Collagen Induced Arthritis with Altered Peptide Ligands
用改变的肽配体抑制胶原诱导的关节炎
- 批准号:
7578745 - 财政年份:2009
- 资助金额:
$ 55.21万 - 项目类别:
Suppression of Collagen Induced Arthritis with Altered Peptide Ligands
用改变的肽配体抑制胶原诱导的关节炎
- 批准号:
7914434 - 财政年份:2009
- 资助金额:
$ 55.21万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 55.21万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 55.21万 - 项目类别:
Research Grant
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 55.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 55.21万 - 项目类别:
Operating Grants
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 55.21万 - 项目类别:
Fellowship
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 55.21万 - 项目类别:
Fibroblast-mediated inflammatory resolution of rheumatoid arthritis
成纤维细胞介导的类风湿性关节炎炎症消退
- 批准号:
10604629 - 财政年份:2023
- 资助金额:
$ 55.21万 - 项目类别:
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
- 批准号:
10822182 - 财政年份:2023
- 资助金额:
$ 55.21万 - 项目类别:
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
- 批准号:
10733789 - 财政年份:2023
- 资助金额:
$ 55.21万 - 项目类别:
Microbial metabolites impacting the response to methotrexate in rheumatoid arthritis
微生物代谢物影响类风湿性关节炎对甲氨蝶呤的反应
- 批准号:
10578433 - 财政年份:2023
- 资助金额:
$ 55.21万 - 项目类别: